465 related articles for article (PubMed ID: 34931349)
1. Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R.
Cupido AJ; Asselbergs FW; Natarajan P; ; Ridker PM; Hovingh GK; Schmidt AF
Br J Clin Pharmacol; 2022 Jun; 88(6):2875-2884. PubMed ID: 34931349
[TBL] [Abstract][Full Text] [Related]
2. Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
Yuan S; Lin A; He QQ; Burgess S; Larsson SC
Int J Cardiol; 2020 Aug; 313():99-104. PubMed ID: 32223966
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study.
Zhang K; Jia Y; Wang R; Guo D; Yang P; Sun L; Wang Y; Liu F; Zang Y; Shi M; Zhang Y; Zhu Z
Scand J Rheumatol; 2023 Jul; 52(4):335-341. PubMed ID: 35658786
[TBL] [Abstract][Full Text] [Related]
4. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
; Swerdlow DI; Holmes MV; Kuchenbaecker KB; Engmann JE; Shah T; Sofat R; Guo Y; Chung C; Peasey A; Pfister R; Mooijaart SP; Ireland HA; Leusink M; Langenberg C; Li KW; Palmen J; Howard P; Cooper JA; Drenos F; Hardy J; Nalls MA; Li YR; Lowe G; Stewart M; Bielinski SJ; Peto J; Timpson NJ; Gallacher J; Dunlop M; Houlston R; Tomlinson I; Tzoulaki I; Luan J; Boer JM; Forouhi NG; Onland-Moret NC; van der Schouw YT; Schnabel RB; Hubacek JA; Kubinova R; Baceviciene M; Tamosiunas A; Pajak A; Topor-Madry R; Malyutina S; Baldassarre D; Sennblad B; Tremoli E; de Faire U; Ferrucci L; Bandenelli S; Tanaka T; Meschia JF; Singleton A; Navis G; Mateo Leach I; Bakker SJ; Gansevoort RT; Ford I; Epstein SE; Burnett MS; Devaney JM; Jukema JW; Westendorp RG; Jan de Borst G; van der Graaf Y; de Jong PA; Mailand-van der Zee AH; Klungel OH; de Boer A; Doevendans PA; Stephens JW; Eaton CB; Robinson JG; Manson JE; Fowkes FG; Frayling TM; Price JF; Whincup PH; Morris RW; Lawlor DA; Smith GD; Ben-Shlomo Y; Redline S; Lange LA; Kumari M; Wareham NJ; Verschuren WM; Benjamin EJ; Whittaker JC; Hamsten A; Dudbridge F; Delaney JA; Wong A; Kuh D; Hardy R; Castillo BA; Connolly JJ; van der Harst P; Brunner EJ; Marmot MG; Wassel CL; Humphries SE; Talmud PJ; Kivimaki M; Asselbergs FW; Voevoda M; Bobak M; Pikhart H; Wilson JG; Hakonarson H; Reiner AP; Keating BJ; Sattar N; Hingorani AD; Casas JP
Lancet; 2012 Mar; 379(9822):1214-24. PubMed ID: 22421340
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study.
Hamilton FW; Thomas M; Arnold D; Palmer T; Moran E; Mentzer AJ; Maskell N; Baillie K; Summers C; Hingorani A; MacGowan A; Khandaker GM; Mitchell R; Davey Smith G; Ghazal P; Timpson NJ
PLoS Med; 2023 Jan; 20(1):e1004174. PubMed ID: 36716318
[TBL] [Abstract][Full Text] [Related]
6. Contribution of metabolic risk factors and lifestyle behaviors to cardiovascular disease: A mendelian randomization study.
Jia Y; Wang R; Guo D; Sun L; Shi M; Zhang K; Yang P; Zang Y; Wang Y; Liu F; Zhang Y; Zhu Z
Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1972-1981. PubMed ID: 35610082
[TBL] [Abstract][Full Text] [Related]
7. Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.
Interleukin 1 Genetics Consortium
Lancet Diabetes Endocrinol; 2015 Apr; 3(4):243-53. PubMed ID: 25726324
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory biomarkers and risk of ischemic stroke and subtypes: A 2-sample Mendelian randomization study.
Lin J; Wang Y; Wang Y; Pan Y
Neurol Res; 2020 Feb; 42(2):118-125. PubMed ID: 31900081
[No Abstract] [Full Text] [Related]
9. Sex-Specific Reproductive Factors Augment Cardiovascular Disease Risk in Women: A Mendelian Randomization Study.
Ardissino M; Slob EAW; Carter P; Rogne T; Girling J; Burgess S; Ng FS
J Am Heart Assoc; 2023 Mar; 12(5):e027933. PubMed ID: 36846989
[TBL] [Abstract][Full Text] [Related]
10. Mendelian randomization study on the causal effects of tumor necrosis factor inhibition on coronary artery disease and ischemic stroke among the general population.
Kang X; Jiao T; Wang H; Pernow J; Wirdefeldt K
EBioMedicine; 2022 Feb; 76():103824. PubMed ID: 35074627
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of cytokines and risk of cardiovascular disease: a Mendelian randomization study.
Wei T; Zhu Z; Liu L; Liu B; Wu M; Zhang W; Cui Q; Liu F; Zhang R
Front Immunol; 2023; 14():1175421. PubMed ID: 37304261
[TBL] [Abstract][Full Text] [Related]
12. Genetic Liability to Rheumatoid Arthritis in Relation to Coronary Artery Disease and Stroke Risk.
Yuan S; Carter P; Mason AM; Yang F; Burgess S; Larsson SC
Arthritis Rheumatol; 2022 Oct; 74(10):1638-1647. PubMed ID: 35583917
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis investigating the role of interleukin-6 mediated inflammation in type 2 diabetes.
Bowker N; Shah RL; Sharp SJ; Luan J; Stewart ID; Wheeler E; Ferreira MAR; Baras A; Wareham NJ; Langenberg C; Lotta LA
EBioMedicine; 2020 Nov; 61():103062. PubMed ID: 33096487
[TBL] [Abstract][Full Text] [Related]
14. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases.
Ferreira RC; Freitag DF; Cutler AJ; Howson JM; Rainbow DB; Smyth DJ; Kaptoge S; Clarke P; Boreham C; Coulson RM; Pekalski ML; Chen WM; Onengut-Gumuscu S; Rich SS; Butterworth AS; Malarstig A; Danesh J; Todd JA
PLoS Genet; 2013 Apr; 9(4):e1003444. PubMed ID: 23593036
[TBL] [Abstract][Full Text] [Related]
15. Gene-centric analysis identifies variants associated with interleukin-6 levels and shared pathways with other inflammation markers.
Shah T; Zabaneh D; Gaunt T; Swerdlow DI; Shah S; Talmud PJ; Day IN; Whittaker J; Holmes MV; Sofat R; Humphries SE; Kivimaki M; Kumari M; Hingorani AD; Casas JP
Circ Cardiovasc Genet; 2013 Apr; 6(2):163-70. PubMed ID: 23505291
[TBL] [Abstract][Full Text] [Related]
16. Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases.
Wu D; Gong Z; Hao X; Liu L
J Transl Med; 2024 Jun; 22(1):581. PubMed ID: 38898459
[TBL] [Abstract][Full Text] [Related]
17. Causal relationship of interleukin-6 and its receptor on sarcopenia traits using mendelian randomization.
Chen B; Li S; Lin S; Dong H
Nutr J; 2024 May; 23(1):51. PubMed ID: 38750566
[TBL] [Abstract][Full Text] [Related]
18. A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis.
Esparza-Gordillo J; Schaarschmidt H; Liang L; Cookson W; Bauerfeind A; Lee-Kirsch MA; Nemat K; Henderson J; Paternoster L; Harper JI; Mangold E; Nothen MM; Rüschendorf F; Kerscher T; Marenholz I; Matanovic A; Lau S; Keil T; Bauer CP; Kurek M; Ciechanowicz A; Macek M; Franke A; Kabesch M; Hubner N; Abecasis G; Weidinger S; Moffatt M; Lee YA
J Allergy Clin Immunol; 2013 Aug; 132(2):371-7. PubMed ID: 23582566
[TBL] [Abstract][Full Text] [Related]
19. Frailty and cardiometabolic diseases: a bidirectional Mendelian randomisation study.
Zhu J; Zhou D; Wang J; Yang Y; Chen D; He F; Li Y
Age Ageing; 2022 Nov; 51(11):. PubMed ID: 36346739
[TBL] [Abstract][Full Text] [Related]
20. Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis.
Prapiadou S; Živković L; Thorand B; George MJ; van der Laan SW; Malik R; Herder C; Koenig W; Ueland T; Kleveland O; Aukrust P; Gullestad L; Bernhagen J; Pasterkamp G; Peters A; Hingorani AD; Rosand J; Dichgans M; Anderson CD; Georgakis MK
Circulation; 2024 Feb; 149(9):669-683. PubMed ID: 38152968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
